J&J Stent Patents Found Invalid In Boston Sci Suit

Law360, New York (January 22, 2010, 10:43 AM EST) -- Boston Scientific Corp. has prevailed in a consolidated suit against Johnson & Johnson Inc., now that a federal judge has found invalid four J&J patents for a drug-eluting stent.

The summary judgment ruling Wednesday by Judge Sue L. Robinson of the U.S. District Court for the District of Delaware halted a trial that was to begin in February.

In a memorandum opinion, Judge Robinson held that the disputed claims of the four patents — which J&J alleged were infringed by the Promus stent system produced by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.